Upon binding to CRC cells, FadA further elevates ANXA1 expression in a positive feedback loop, exacerbating CRC progression (Meng et al, 2021; Rubinstein et al, 2019; Rubinstein et al, 2013). Here, ANXA1 is linked to colorectal carcinoma.